10
Feb
Antitrust Issues in Generic Substitution: How Pharma Tactics Block Cheaper Drugs
Pharmacy

Antitrust Issues in Generic Substitution: How Pharma Tactics Block Cheaper Drugs

Pharmaceutical companies are using legal loopholes to block generic drugs from entering the market, costing patients billions. Learn how product hopping, REMS abuse, and withdrawal tactics undermine substitution laws-and what regulators are doing about it.

Caden Aldridge